Episode
New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC
- Podcast
- Touching Base
- Published
- Nov 20, 2025
- Duration seconds
- 2510
- Processing state
not_requested- Canonical source
- https://shows.acast.com/touching-base/episodes/new-nasal-vaccines-korro-stock-dips-jj-and-merck-acquisition
Actions
POST https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/new-nasal-vaccines-korro-stock-dips-j-j-and-merck-acquisitions-and-dyno-gatc/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/touching-base-6714887/new-nasal-vaccines-korro-stock-dips-j-j-and-merck-acquisitions-and-dyno-gatc.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Nasal vaccines show new promise for human papillomavirus (HPV) to address cervical cancer and whooping cough. In business news, Korro's stock craters 81% as AATD interim Phase I/II results miss expectations. Additionally, Johnson & Johnson acquires Halda to expand their cancer pipeline while Merck acquires Cidara to boost antivirals. Lastly, the inaugural Genetic Agency Technology Conference (GATC) hosted by Dyno Therapeutics brought together a diverse group of researchers, entrepreneurs, and patient advocates to discuss the mission of genetic agency, or an individual’s ability to take action at the genetic level to live a healthier life. Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news. Listed below are links to the GEN stories referenced in this episode of Touching Base : Cervical Cancer May Be Treatable with Intranasal Nanogel Vaccine GEN , November 15, 2025 Novel Nasal Spray Vaccine for Pertussis Shows Promise By Corinna Singleman, PhD, GEN , November 12, 2025 StockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia By Alex Philippidis, GENEdge , November 16, 2025 J&J Expands Cancer Pipeline with $3B Halda Acquisition By Alex Philippidis, GENEdge , November 18, 2025 Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline By Alex Philippidis, GEN , November 15, 2025 AI Meets Genetic Agency at Dyno GATC 2025 By Fay Lin, PhD, GENEdge , November 14, 2025 Genetic Agency on Display at GATC 2025 By Kevin Davies, PhD, and Fay Lin, PhD, GEN , November 13, 2025 Dyno GATC Announces AI Agents, Muscle Capsid, and Manufacturing Partner By Fay Lin, PhD, GEN Edge , November 11, 2025 &nb…